These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11604476)

  • 1. 1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice.
    Colussi C; Fiumicino S; Giuliani A; Rosini S; Musiani P; Macrí C; Potten CS; Crescenzi M; Bignami M
    J Natl Cancer Inst; 2001 Oct; 93(20):1534-40. PubMed ID: 11604476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous and mutagen-induced transformation of primary cultures of Msh2-/- p53-/- colonocytes.
    Sevignani C; Cranston A; Iozzo RV; Fishel R; Calabretta B
    Cancer Res; 1999 Dec; 59(23):5882-6. PubMed ID: 10606228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
    Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
    Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair deficiency stimulates N-ethyl-N-nitrosourea-induced mutagenesis and lymphomagenesis.
    Claij N; van der Wal A; Dekker M; Jansen L; te Riele H
    Cancer Res; 2003 May; 63(9):2062-6. PubMed ID: 12727820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Msh2 DNA mismatch repair gene deficiency and the food-borne mutagen 2-amino-1-methy1-6-phenolimidazo [4,5-b] pyridine (PhIP) synergistically affect mutagenesis in mouse colon.
    Zhang S; Lloyd R; Bowden G; Glickman BW; de Boer JG
    Oncogene; 2001 Sep; 20(42):6066-72. PubMed ID: 11593414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine.
    Toft NJ; Winton DJ; Kelly J; Howard LA; Dekker M; te Riele H; Arends MJ; Wyllie AH; Margison GP; Clarke AR
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3911-5. PubMed ID: 10097137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Msh-2 suppresses in vivo mutation in a gene dose and lesion dependent manner.
    Sansom OJ; Toft NJ; Winton DJ; Clarke AR
    Oncogene; 2001 Jun; 20(27):3580-4. PubMed ID: 11429706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent colon carcinogen, 1,2-dimethylhydrazine induces mutations primarily in the colon.
    Newell LE; Heddle JA
    Mutat Res; 2004 Nov; 564(1):1-7. PubMed ID: 15474405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents.
    Humbert O; Fiumicino S; Aquilina G; Branch P; Oda S; Zijno A; Karran P; Bignami M
    Carcinogenesis; 1999 Feb; 20(2):205-14. PubMed ID: 10069455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair.
    Pichierri P; Franchitto A; Piergentili R; Colussi C; Palitti F
    Carcinogenesis; 2001 Nov; 22(11):1781-7. PubMed ID: 11698339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous and mutagen-induced loss of DNA mismatch repair in Msh2-heterozygous mammalian cells.
    Borgdorff V; van Hees-Stuivenberg S; Meijers CM; de Wind N
    Mutat Res; 2005 Jul; 574(1-2):50-7. PubMed ID: 15914206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to DNA cross-linking chemotherapeutic agents in mismatch repair-defective cells in vitro and in xenografts.
    Fiumicino S; Martinelli S; Colussi C; Aquilina G; Leonetti C; Crescenzi M; Bignami M
    Int J Cancer; 2000 Feb; 85(4):590-6. PubMed ID: 10699935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate mutator genes in mismatch repair-deficient thymic lymphomas: no evidence of mutations in the DNA polymerase delta gene.
    Campbell MR; Thang TY; Jirik FR; Andrew SE
    Carcinogenesis; 2000 Dec; 21(12):2281-5. PubMed ID: 11133819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HNPCC-like cancer predisposition in mice through simultaneous loss of Msh3 and Msh6 mismatch-repair protein functions.
    de Wind N; Dekker M; Claij N; Jansen L; van Klink Y; Radman M; Riggins G; van der Valk M; van't Wout K; te Riele H
    Nat Genet; 1999 Nov; 23(3):359-62. PubMed ID: 10545954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Msh2-deficient mice to inflammation-associated colorectal tumors.
    Kohonen-Corish MR; Daniel JJ; te Riele H; Buffinton GD; Dahlstrom JE
    Cancer Res; 2002 Apr; 62(7):2092-7. PubMed ID: 11929830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary n-3 PUFA increases the apoptotic response to 1,2-dimethylhydrazine, reduces mitosis and suppresses the induction of carcinogenesis in the rat colon.
    Latham P; Lund EK; Johnson IT
    Carcinogenesis; 1999 Apr; 20(4):645-50. PubMed ID: 10223194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats.
    Anisimov VN; Popovich IG; Shtylik AV; Zabezhinski MA; Ben-Huh H; Gurevich P; Berman V; Tendler Y; Zusman I
    Exp Toxicol Pathol; 2000 Mar; 52(1):71-6. PubMed ID: 10779155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
    Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
    Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.